Marco Loi, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1440 Main St, Waltham, MA 02451 Phone: 781-891-9300 Fax: 781-891-9305 |
Karapet Guyumdzhyan, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1440 Main St, Waltham, MA 02451 Phone: 781-891-9300 Fax: 781-891-9305 |
Mr. John E Mcnemar, DNAP, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 40 2nd Ave, Waltham, MA 02451 Phone: 781-487-2999 |
Susan Melanson Payne, Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 85 1st Ave, Waltham, MA 02451 Phone: 781-647-7246 |
Kathleen D Harrington, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 40 Second Avenue, Suite 200 Mgh Orthopaedic Ambulatory Surgery Center, Waltham, MA 02451 Phone: 781-487-2900 |
Judith A Manzer, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 40 Second Ave, Suite 200, Waltham, MA 02451 Phone: 781-487-2900 |
Jennifer L Smith, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1440 Main St, Waltham, MA 02451 Phone: 781-891-9300 Fax: 781-891-9305 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today results from long-term stability studies of its proprietary DNI anthrax rPA subunit protein vaccine, known as SGX204.
Washington State University researchers have determined how a protein that helps cells fight viruses can also cause genetic mutations that lead to cancer.
Zebra Medical Vision announces today the CE regulatory approval of its newest algorithm to be included in its growing Deep Learning Imaging Analytics platform.
The American Academy of Ophthalmology will pay tribute to outstanding eye physicians and surgeons who have made significant achievements in various areas of the profession. These range from scientific innovation and humanitarian service to education and advocacy. The honorees will be recognized AAO 2015, the Academy's 119th annual meeting in Las Vegas.
Omeros Corporation today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement. OMS302 is the company's proprietary Pharmacosurgery product being developed for all ILR, including cataract surgery and refractive lens exchange.
› Verified 3 days ago